Advertisement
Screener

ENLIVEN THERAPEUTICS, INC. (ELVN) ROA

ENLIVEN THERAPEUTICS, INC. (ELVN) ROA

  • 2026-06-30: ROA -11.64%.
  • 2026-03-31: ROA -21.25%.
  • 2025-12-31: ROA -21.78%.
  • 2025-09-30: ROA -19.80%.

Complete source-backed roa history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-11.64%
2026-03-31-21.25%
2025-12-31-21.78%
2025-09-30-19.80%
2025-06-30-19.89%
2025-03-31-31.34%
2024-12-31-27.33%
2024-09-30-27.90%
2024-06-30-25.33%
2024-03-31-23.22%
2023-12-31-26.33%
2023-09-30-22.54%
2023-06-30-17.87%
2023-03-31-14.43%
2022-12-31-45.21%
2022-09-30-71.79%
2022-06-30-70.40%
2022-03-31-61.02%
2021-12-31-54.87%
2021-09-30-45.39%
2021-06-30-65.35%
2021-03-31-54.36%
2020-12-31-45.53%
2020-09-30-37.03%
2020-06-30-28.11%
2020-03-31-24.01%
2019-12-31-70.46%

Annual ROA

DateROA
2025-12-31-21.78%
2024-12-31-27.33%
2023-12-31-26.33%
2022-12-31-45.21%
2021-12-31-54.87%
2020-12-31-45.53%
2019-12-31-70.46%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
Arcus Biosciences, Inc. (RCUS)United States$3.188B-8.52
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Organon & Co. (OGN)United States$3.603B17.03
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
PRECIGEN, INC. (PGEN)United States$2.757B-12.94
AbCellera Biologics Inc. (ABCL)$3.879B-14.59